| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cae888491722362ea0110204d70abfeb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6081 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-21 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| filingDate |
2013-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a3d7722c36245508b89814a754ea372
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aad8eca2a1535ec51826c82a7b48a239
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14c21b85a91911403588d5baf5e24a18 |
| publicationDate |
2015-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2014014526-A |
| titleOfInvention |
IMMUNOGENIC COMPOUNDS THAT INCLUDE PEPTIDE OF TRANSMEMBRANE PROTEIN 41 (GP41) OF THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) COUPLED TO CRM197 TRANSPORTING PROTEIN. |
| abstract |
The present invention relates to the field of vaccines directed against viruses of the HIV family. More particularly, it refers to an immunogenic compound comprising a peptide of the following formula (I) NH2- [Nt] and PWNXS-X2-SN-X3-X4-X5-X6-X7-I -W- [Ct] z- COOH (I), which is covalently bound to a carrier protein consisting of a CRM197 protein. It also refers to a composition containing this immunogenic compound and the uses of these immunogenic compounds and compositions to prevent and / or treat a condition caused by the infection of an individual with an HIV virus. |
| priorityDate |
2012-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |